Abstract
Heart failure (HF) is a common disease with high morbidity and mortality; however, none of the drugs available are now entirely optimal for the treatment of HF. In addition to various clinical diseases and environment influences, genetic factors also contribute to the development and progression of HF. Identifying the common variants for HF by genome-wide association studies will facilitate the understanding of pathophysiological mechanisms underlying HF. This review summarizes the recently identified common variants for HF risk and outcome and discusses their implications for the clinic therapy.
Keywords: Common variants, Dilated cardiomyopathy, Genome-wide association studies, Heart failure, Mortality, Risk.
Graphical Abstract
Related Journals
Related Books
Applied Biomathematics for Nucleic Acid Chemistry and Protein Folding: Quantitative Simulations
Industrial Applications of Soil Microbes
Molecular and Physiological Insights into Plant Stress Tolerance and Applications in Agriculture
Systems Biology, Bioinformatics and Livestock Science
Advances in Legume Research: Physiological Responses and Genetic Improvement for Stress Resistance
Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach
Future Farming: Advancing Agriculture with Artificial Intelligence
Genome Size and Genetic Homogeneity of Regenerated Plants: Methods and Applications
The Drone Honey Bee
Fungal Lipid Biochemistry
23
2
1